VITROS Anti-SARS-CoV-2 Total Reagent, COV2TOT, VITROS CoV2T. Catalog number 6199922, UDI 10758750...

FDA Device Recall #Z-2770-2020 — Class II — July 17, 2020

Recall Summary

Recall Number Z-2770-2020
Classification Class II — Moderate risk
Date Initiated July 17, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Ortho Clinical Diagnostics
Location Rochester, NY
Product Type Devices
Quantity 47,271 sales units

Product Description

VITROS Anti-SARS-CoV-2 Total Reagent, COV2TOT, VITROS CoV2T. Catalog number 6199922, UDI 10758750033386 - Product Usage: Rx ONLY. For in vitro diagnostic and Laboratory Professional use. For emergency authorization use only.

Reason for Recall

The reagent bottles may be swapped within the reagent pack, which may lead to false negative results or delayed results due to calibration failures, or quality control failures.

Distribution Pattern

Worldwide distribution - US Nationwide distribution.

Lot / Code Information

Lots 0010-0037

Other Recalls from Ortho Clinical Diagnostics

Recall # Classification Product Date
Z-2879-2020 Class II VITROS XT7600 Integrated System, Product code 6... Jul 20, 2020
Z-2878-2020 Class II VITROS XT3400 Chemistry System, Product code 68... Jul 20, 2020
Z-2771-2020 Class II VITROS Anti-SARS-CoV-2 IgG Reagent Pack, COV2Ig... Jul 17, 2020
Z-2484-2020 Class II VITROS XT 7600 Integrated System Software Versi... May 20, 2020
Z-2481-2020 Class II VITROS 3600 Immunodiagnostic System - Refurbish... May 20, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.